Hillsdale Investment Management’s Globus Medical GMED Stock Holding History

Hillsdale Investment Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-43,500	Closed	-$3.75M	–	699
2026 Q1	$3.75M	Buy	43,500 +2,000	+5%	+$180K	0.1%	246
2025 Q4	$3.62M	Buy	+41,500	New	+$3.15M	0.1%	275
2023 Q3	–	Sell	-180	Closed	-$10.7K	–	600
2023 Q2	$10.7K	Sell	180 -7,100	-98%	-$405K	﹤0.01%	435
2023 Q1	$412K	Buy	+7,280	New	+$467K	0.04%	369
2020 Q2	–	Sell	-81,100	Closed	-$3.45M	–	617
2020 Q1	$3.45M	Sell	81,100 -400	-0.5%	-$19.8K	0.42%	56
2019 Q4	$4.8M	Buy	+81,500	New	+$4.42M	0.42%	64
2019 Q3	–	Sell	-35,000	Closed	-$1.48M	–	641
2019 Q2	$1.48M	Hold	35,000	–	–	0.15%	151
2019 Q1	$1.73M	Hold	35,000	–	–	0.16%	135
2018 Q4	$1.51M	Buy	35,000 +7,000	+25%	+$349K	0.18%	134
2018 Q3	$1.59M	Buy	28,000 +2,000	+8%	+$105K	0.21%	97
2018 Q2	$1.31M	Buy	+26,000	New	+$1.36M	0.16%	143

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Hillsdale Investment Management's GMED Position: Q2 2026 in Review

Hillsdale Investment Management sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 43,500 shares — an estimated $3.75M sold.

Hillsdale Investment Management first reported a position in GMED in Q2 2018 and held it in 11 quarters. The position peaked at $4.8M in Q4 2019. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Hillsdale Investment Management reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
Hillsdale Investment Management sold 43,500 Globus Medical shares in Q2 2026, an estimated $3.75M.
Hillsdale Investment Management first reported a position in Globus Medical in Q2 2018 and held it in 11 quarters.
Hillsdale Investment Management's Globus Medical position peaked at $4.8M in Q4 2019.
601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Hillsdale Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.